… INR range of 2 to 3, patients with AF receiving warfarin spent 61% of time within, 13% of …
with patients with nonvalvular AF receiving warfarin as long as they reported the outcomes of …

… Vitamin K antagonist (eg, warfarin) use is nowadays challenged by the non–vitamin K antagonist
… NOAC studies were based on comparisons with warfarin arms with times in therapeutic …

Using data from ARISTOTLE, we describe the periprocedural management of anticoagulation
and rates of subsequent clinical outcomes among patients chronically anticoagulated with …

… of warfarin-eligible patients who received warfarin in studies that measured that outcome. A
… low percentage of their time within the therapeutic INR range while on warfarin (55%, 95% …

… We asked patients to answer questions relating to their warfarin therapy and used multivariable
… was associated with nonadherence to warfarin as well as time in therapeutic INR range. …

… For this analysis, we determined the percentage time each patient assigned to warfarin
therapy was in the therapeutic range during the study. A daily INR was calculated based on …

… The purpose of the present study was to evaluate the association between mean TTR of
AF patient populations on warfarin therapy and the occurrence of patient-relevant outcomes …

… outcomes in a cohort of patients with well-managed warfarin therapy, clinical medicine is
practiced in real-time and decisions about whether to prescribe anticoagulation for a patient …

… expressed by the time in therapeutic range (TTR). Both … patients taking warfarin were
receiving antiplatelet therapy at some point, only 2 studies actually measured outcomes in patients …

… time in therapeutic range (TTR), and incidence of major and minor bleeding, thrombosis,
warfarin-related emergency, and warfarin-… TTR of patients on long-term warfarin anticoagulants …